BioAtla Investor Presentation Deck

Dosing regimens under evaluation for CAB-ROR2-ADC BA3021 Ozuriftamab Vedotin All cycles (28 days) All cycles (21 days) Cycle 1 (21 days) Cycle 2 (28 days) and subsequent cycles bicatla Source: Form 10-K Q2W 2Q3W 3Q4W Day 1 1.8 mg/kg Day 8 2.0 mg/kg 1.3 mg/kg Dose no drug 1.8 mg/kg 1.8 mg/kg 1.3 mg/kg 1.3 mg/kg Day 15 1.8 mg/kg no drug 1.3 mg/kg 1.3 mg/kg Day 22 no drug no drug BioAtla| Overview 33

View entire presentation